Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Apr 6;11(2):59.
doi: 10.3390/diseases11020059.

Association between Multiple Myeloma and Ulcerative Colitis: A Cross-Sectional Analysis

Ayrton Bangolo  1 , Sowmya Sagireddy  1 , Paul Desrochers  1 , Imane Laabidi  1 , Vignesh K Nagesh  1 , Amer Jarri  1 , Imranjot Sekhon  1 , Youssef Laabidi  1 , Deeksha Muralidhar  1 , Adarshpreet Singh  1 , Paranjyothy R P Sanjeeva  1 , Damanpartap S Sandhu  1 , Saba Salma  1 , Saad A Khan  1 , Mir I Ali  1 , Sung H Kim  1 , Wardah Bajwa  1 , Angela C Tai  1 , Assma Itani  1 , Kareem Ahmed  2 , Mevlut Ozmen  1 , Bhargav Hirpara  1 , Shruti M Borse  1 , Simcha Weissman  1
Affiliations

Association between Multiple Myeloma and Ulcerative Colitis: A Cross-Sectional Analysis

Ayrton Bangolo et al. Diseases. .

Abstract

Background and aims: Multiple myeloma (MM) is a plasma cell dyscrasia that is common among patients with autoimmune diseases. However, the association between ulcerative colitis (UC) and multiple myeloma (MM) is yet to be established. We aimed to evaluate the prevalence of MM among patients with UC in the United States.

Methods: This cross-sectional cohort analysis used the National Inpatient Sample from 2015-2018 to assess the overall MM prevalence among patients with and without UC, and within specific demographic subgroups. Prevalences were compared using a logistic regression model controlling for sex and age.

Results: The crude prevalence of MM among patients with UC (n = 1750) compared with patients without UC (n = 366,265) was 0.44% vs. 0.37%, respectively. Patients with UC had increased overall odds of having MM (odds ratio (OR), 1.26). Males with UC had higher prevalence of MM (53.7% vs. 46.3%, respectively) than females. Patients with UC and MM were more likely to be African American than White (15.6% vs. 9.2%, respectively). Patients with UC age >64 had a higher prevalence of MM than those aged below 65 (70.9% vs. 29.1%, respectively). Patients with UC who were obese (BMI > 30) had a higher prevalence of MM than those who were non-obese (12.6% vs. 8.3%).

Conclusions: Overall, UC appears to be associated with MM. This association can be particularly observed in specific demographic groups, such as obese, African American males, or patients >64 years of age. Thus, a high degree of clinical suspicion for MM is warranted, even with minimal symptomatology, in patients with UC, in particular among elder, obese, and African American males.

Keywords: IBD; cross sectional analysis; multiple myeloma; plasma cell dyscrasia; ulcerative colitis.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Similar articles

See all similar articles

Cited by

References

    1. Lindqvist E.K., Landgren O., Lund S.H., Turesson I., Hultcrantz M., Goldin L., Björkholm M., Kristinsson S.Y. History of autoimmune disease is associated with impaired survival in multiple myeloma and monoclonal gammopathy of undetermined significance: A population-based study. Ann. Hematol. 2017;96:261–269. doi: 10.1007/s00277-016-2859-8. - DOI - PMC - PubMed
    1. Siegel R.L., Miller K.D., Fuchs H.E., Jemal A. Cancer statistics, 2022. CA Cancer J. Clin. 2022;72:7–33. doi: 10.3322/caac.21708. - DOI - PubMed
    1. Gandhi M., Bakhai V., Trivedi J., Mishra A., De Andrés F., LLerena A., Sharma R., Nair S. Current perspectives on interethnic variability in multiple myeloma: Single cell technology, population pharmacogenetics and molecular signal transduction. Transl. Oncol. 2022;25:101532. doi: 10.1016/j.tranon.2022.101532. - DOI - PMC - PubMed
    1. Christodoulidis G., Perivoliotis K., Manolakis A., Diamantis A., Koffas A., Magouliotis D., Pappi V., Zacharoulis D. Ulcerative Colitis in Hematological Malignancies: Paraneoplastic Manifestation or Coincidental Bystander? Case Rep. Gastrointest. Med. 2020;2020:6135425. doi: 10.1155/2020/6135425. - DOI - PMC - PubMed
    1. Yadav S., Kumar R., Jaiyesimi I.A., Chisti M.M. Aggressive plasmablastic multiple myeloma in a 42-year-old: Is inflammatory bowel disease or infliximab treatment to be blamed? BMJ Case Rep. 2013;2013:bcr2013200607. doi: 10.1136/bcr-2013-200607. - DOI - PMC - PubMed

LinkOut - more resources